Trial intelligence / Profile preview

Humira in Psoriasis and Obstructive Sleep Apnea

NCT01181570Phase 4Completed

Sponsor
Innovaderm Research
Start
Sep 2010
Primary completion
Aug 2011
Modality
Monoclonal Antibodies
Countries
1
01

Overview

A Phase 4 trial of adalimumab in obstructive sleep apnea (OSA), sponsored by Innovaderm Research. Started Sep 2010; status: completed.

02

Drugs

03

Conditions

obstructive sleep apnea (OSA)

Beyond the preview

Go deeper on NCT01181570.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01181570.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call